All In Biotech

Drug Trial Radar · NCT07682558

Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management

Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management: a Double-blind, Randomized, Three Arm, Placebo Controlled Trial Assessing the Key Non-opioids Dipyrone (Metamizole) and Ibuprofen

Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 318 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

318

Planned (sponsor's estimate)

Start

Oct 2026

Primary completion

Nov 2029

Study completion Nov 2029

Sponsor

Lead sponsor
University Hospital, Basel, SwitzerlandAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Swiss GO Trial Group; Swiss National Science Foundation
First posted
Jul 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators investigate the efficacy of non-opioid analgesics compared to placebo together with opioid therapy for cancer pain management.

Conditions

  • Cancer Pain
  • Cancer Palliative Care

Interventions

  • MetamizoleDrug

    Metamizole 4 g/d as: 2 capsules of 500 mg Metamizole each (1000 mg) taken 4 x daily orally.

  • IbuprofenDrug

    Ibuprofen 1.2 g/d as: 2 capsules of 150 mg Ibuprofen each (300 mg) taken 4 x daily orally

  • PlaceboOther

    Placebo 0 g/d as: 2 capsules containing inactive substance (mannitol) taken 4 x daily orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in cancer painTime frame: up to 5 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital Basel

    Basel, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.